A PHASE III, MULTICENTER, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF THE ADDITION OF SITAGLIPTIN COMPARED TO THE ADDITION OF GLIMEPIRIDE IN PATIENTS WITH DIABETES MELLITUS TYPE 2 AND WITH INAPPROPRIATE GLYCEMIC CONTROL RECEIVING METFORMIN

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2008
This article has no abstract
Epistemonikos ID: ca8dc41e27ee4821ed4e693e2045a0d9d4a8f7ab
First added on: Apr 16, 2025